Sign In
Buy PBH
$45.44
-0.390 (-0.85%)
At Close: Jun 03, 2026
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022
02:17pm, Tuesday, 10'th May 2022 Benzinga
Upgrades
According to Nomura Instinet, the prior rating for Goodyear Tire & Rubber Co (NASDAQ:GT) was changed from Neutral to Buy. In the first quarter, Goodyear Tire & Rubber showed an EPS of $0.37,
27 Recession-Resistant Stocks To Look At Now
05:26pm, Monday, 09'th May 2022 Benzinga
When we enter a period of economic uncertainty, the phrase "recession-proof stocks" is tossed about, but really the only certainty is that recession-proof stocks do not exist.
On the other hand, reces
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022
02:07pm, Monday, 09'th May 2022 Benzinga
Upgrades
For Axogen Inc (NASDAQ:AXGN), Canaccord Genuity upgraded the previous rating of Hold to Buy. Axogen earned $0.20 in the first quarter, compared to $0.08 in the year-ago quarter. The stock has
Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2022 Results - Earnings Call Transcript
12:48pm, Friday, 06'th May 2022
Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q4 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Phil Terpolilli - VP, IR Ron Lombardi - Chairman, President and CEO Christine
Prestige Consumer (PBH) Stock Up on Q4 Earnings & Revenue Beat
11:46am, Friday, 06'th May 2022 Zacks Investment Research
Prestige Consumer's (PBH) fourth-quarter results benefit from strong consumer demand and strength in certain categories that were earlier affected by the pandemic.
Prestige Consumer (PBH) Stock Up on Q4 Earnings & Revenue Beat
09:02am, Friday, 06'th May 2022
Prestige Consumer's (PBH) fourth-quarter results benefit from strong consumer demand and strength in certain categories that were earlier affected by the pandemic.
Prestige Brands (PBH) Tops Q4 Earnings and Revenue Estimates
12:25am, Friday, 06'th May 2022 Zacks Investment Research
Prestige Brands (PBH) delivered earnings and revenue surprises of 2.25% and 3.38%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Prestige Brands (PBH) Tops Q4 Earnings and Revenue Estimates
09:49pm, Thursday, 05'th May 2022
Prestige Brands (PBH) delivered earnings and revenue surprises of 2.25% and 3.38%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Prestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022
08:30pm, Thursday, 05'th May 2022 GlobeNewswire Inc.
TARRYTOWN, N.Y., May 05, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2022.
Central Garden (CENT) Q2 Earnings and Revenues Beat Estimates
09:35pm, Wednesday, 04'th May 2022 Zacks Investment Research
Central Garden (CENT) delivered earnings and revenue surprises of 7.63% and 2.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Prestige Consumer (PBH) in Q4 Earnings?
01:29pm, Wednesday, 04'th May 2022 Zacks Investment Research
Prestige Consumer's (PBH) fourth-quarter results are likely to reflect high demand for certain categories and gains from buyouts, while high costs are a concern.
Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Fourth Quarter and Year-End Earnings Results
12:53pm, Thursday, 14'th Apr 2022 GlobeNewswire Inc.
TARRYTOWN, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 fourth quarter and year-end earnings release on Th
Prestige Consumer (PBH) Hurt by High Costs, Solid Demand Aids
11:54am, Tuesday, 12'th Apr 2022 Zacks Investment Research
Prestige Consumer Healthcare (PBH) is battling elevated cost and supply-chain challenges, while domestic consumer healthcare demand for certain categories has been aiding the company.
Prestige Consumer (PBH) Hurt by High Costs, Solid Demand Aids
09:02am, Tuesday, 12'th Apr 2022
Prestige Consumer Healthcare (PBH) is battling elevated cost and supply-chain challenges, while domestic consumer healthcare demand for certain categories has been aiding the company.
Prestige Consumer (PBH) Well Poised on Solid Brand, E-Commerce
12:25pm, Monday, 14'th Mar 2022 Zacks Investment Research
Prestige Consumer Healthcare (PBH) has been gaining on its robust brand portfolio. Prudent acquisitions and e-commerce strength are working well for the company.
